Evidence map›Paper›PMID 41409738›Full record

ArticleEJHaem2025

Development of Machine-Assisted, Human-Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic Syndromes.

Kiyoyuki Ogata, Yuto Mochimaru, Leonie Saft, Gerrit Sijm, Bouchra Badaoui, Canan Alhan, Carole Almire, Yosuke Kato, Daisuke Sakamoto, Naoko Chiba and 9 more

Abstract read
In one paragraph

Article in EJHaem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Kiyoyuki OgataDepartment of Haematology Metropolitan Research and Treatment Centre For Blood Disorders (MRTC Japan) Tokyo Japan.ORCID https://orcid.org/0000-0001-7421-9345
Yuto MochimaruDepartment of Haematology Metropolitan Research and Treatment Centre For Blood Disorders (MRTC Japan) Tokyo Japan.
Leonie SaftClinical Pathology and Cancer Diagnostics Karolinska University Hospital and Institute Stockholm Sweden.
Gerrit SijmDepartment of Haematology Amsterdam UMC, VU University Medical Center Cancer Center Amsterdam Amsterdam the Netherlands.
Bouchra BadaouiDepartment of Haematology and Immunology Henri-Mondor Hospital AP-HP Créteil France.
Canan AlhanDepartment of Haematology Amsterdam UMC, VU University Medical Center Cancer Center Amsterdam Amsterdam the Netherlands.
Carole AlmireAssistance Publique-Hôpitaux de Paris. Centre-Université Paris Cité Service d'hématologie biologique, Hôpital Cochin Paris France.
Yosuke KatoDepartment of Medical Technology Kyorin University Faculty of Health Sciences Mitaka Tokyo Japan.
Daisuke SakamotoDepartment of Clinical Laboratory Kyorin University Hospital Mitaka Tokyo Japan.
Naoko ChibaDepartment of Clinical Laboratory Kyorin University Hospital Mitaka Tokyo Japan.
Naho MurataDepartment of Clinical Laboratory Kyorin University Hospital Mitaka Tokyo Japan.
Nana KasaiDepartment of Haematology Metropolitan Research and Treatment Centre For Blood Disorders (MRTC Japan) Tokyo Japan.
Kazuma SeiDepartment of Haematology Metropolitan Research and Treatment Centre For Blood Disorders (MRTC Japan) Tokyo Japan.
Naoya KawaharaDepartment of Haematology Metropolitan Research and Treatment Centre For Blood Disorders (MRTC Japan) Tokyo Japan.
Mika OgataDepartment of Haematology Metropolitan Research and Treatment Centre For Blood Disorders (MRTC Japan) Tokyo Japan.
Nicolas ChapuisAssistance Publique-Hôpitaux de Paris. Centre-Université Paris Cité Service d'hématologie biologique, Hôpital Cochin Paris France.ORCID https://orcid.org/0000-0003-0601-3948
Orianne Wagner-BallonDepartment of Haematology and Immunology Henri-Mondor Hospital AP-HP Créteil France.ORCID https://orcid.org/0000-0001-9071-6683
Arjan van de LoosdrechtDepartment of Haematology Amsterdam UMC, VU University Medical Center Cancer Center Amsterdam Amsterdam the Netherlands.
Yumi YamamotoDepartment of Haematology Metropolitan Research and Treatment Centre For Blood Disorders (MRTC Japan) Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cytomorphological examination and classification of bone marrow (BM) cells using a microscope is essential for diagnosing various diseases affecting the haematopoietic system. However, this requires expertise, is effort-intensive and is inherently subjective. Methods: We developed a method for automatically capturing BM cell images at the single-cell level using an existing cell image analyser designed for peripheral blood. The captured BM cell images were pre-classified by the same analyser and subsequently viewed on a large screen by cytomorphologists for BM cell classification. The data consistency in BM blast percentages between the digital and conventional optical microscopy (CM) methods was examined. Results: During the 3.5-year study period, 657 (96.2%) of the 683 aspirated samples underwent BM cell classification using the digital method. Digital cell images were captured at 2000× magnification and stored permanently, which allowed high-quality cell image analysis at any time by anyone. Cell images could be compared side-by-side across different cell classes, which improves the cell-classification accuracy. The detailed cell morphology in some cases differed slightly between the digital images and CM. BM blast percentage was comparable between the developed method and CM when examining patients with myelodysplastic syndromes (MDS) and other conditions that need to be differentiated from MDS. In a multicentre study, cytomorphologists who used this method for the first time could perform cell classification. Conclusion: This machine-assisted and human-centred approach enhances objectivity in BM cell classification, aligns with the needs of the digital era and facilitates data sharing.

Indexed as

bone marrowcytomorphologydigital imagesmyelodysplastic neoplasmsmyelodysplastic syndromes

Identifiers

PMID41409738
PMCPMC12707303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.